TY - JOUR AU - Sawicki, G. S. AU - Rasouliyan, L. AU - McMullen, A. H. AU - Wagener, J. S. AU - McColley, S. A. AU - Pasta, D. J. PY - 2011 DA - 2011// TI - Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis JO - Pediatr Pulmonol VL - 46 UR - https://doi.org/10.1002/ppul.21325 DO - 10.1002/ppul.21325 ID - Sawicki2011 ER - TY - JOUR AU - Elborn, J. S. PY - 2016 DA - 2016// TI - Cystic fibrosis JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)00576-6 DO - 10.1016/S0140-6736(16)00576-6 ID - Elborn2016 ER - TY - JOUR AU - Mayer-Hamblett, N. AU - Ramsey, B. W. AU - Kronmal, R. A. PY - 2007 DA - 2007// TI - Advancing Outcome Measures for the New Era of Drug Development in Cystic Fibrosis JO - Proceedings of the American Thoracic Society VL - 4 UR - https://doi.org/10.1513/pats.200703-040BR DO - 10.1513/pats.200703-040BR ID - Mayer-Hamblett2007 ER - TY - JOUR AU - Solem, C. T. AU - Vera-Llonch, M. AU - Liu, S. AU - Botteman, M. AU - Castiglione, B. PY - 2016 DA - 2016// TI - Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis JO - Health Qual Life Outcomes VL - 14 UR - https://doi.org/10.1186/s12955-016-0465-z DO - 10.1186/s12955-016-0465-z ID - Solem2016 ER - TY - JOUR AU - Angelis, A. AU - Kanavos, P. AU - López-Bastida, J. AU - Linertová, R. AU - Nicod, E. AU - Serrano-Aguilar, P. PY - 2015 DA - 2015// TI - Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom JO - BMC Health Serv Res VL - 15 UR - https://doi.org/10.1186/s12913-015-1061-3 DO - 10.1186/s12913-015-1061-3 ID - Angelis2015 ER - TY - JOUR AU - Sawicki, G. S. AU - Goss, C. H. PY - 2015 DA - 2015// TI - Tackling the increasing complexity of CF care JO - Pediatr Pulmonol VL - 50 UR - https://doi.org/10.1002/ppul.23244 DO - 10.1002/ppul.23244 ID - Sawicki2015 ER - TY - JOUR AU - Modi, A. C. AU - Quittner, A. L. PY - 2003 DA - 2003// TI - Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis JO - J Pediatr Psych VL - 28 UR - https://doi.org/10.1093/jpepsy/jsg044 DO - 10.1093/jpepsy/jsg044 ID - Modi2003 ER - TY - JOUR AU - Quittner, A. l. e. x. a. n. d. r. a. L. AU - Buu, A. n. n. e. AU - Messer, M. e. l. i. s. s. a. A. AU - Modi, A. v. a. n. i. C. AU - Watrous, M. a. r. c. PY - 2005 DA - 2005// TI - Development and Validation of the Cystic Fibrosis Questionnaire in the United States JO - Chest VL - 128 UR - https://doi.org/10.1378/chest.128.4.2347 DO - 10.1378/chest.128.4.2347 ID - Quittner2005 ER - TY - JOUR AU - Rabin, R. AU - Charro, F. PY - 2001 DA - 2001// TI - EQ-5D: a measure of health status from the EuroQol group JO - Ann Med VL - 33 UR - https://doi.org/10.3109/07853890109002087 DO - 10.3109/07853890109002087 ID - Rabin2001 ER - TY - JOUR AU - Eidt-Koch, D. AU - Mittendorf, T. AU - Greiner, W. PY - 2009 DA - 2009// TI - Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany JO - BMC Pediatr VL - 9 UR - https://doi.org/10.1186/1471-2431-9-55 DO - 10.1186/1471-2431-9-55 ID - Eidt-Koch2009 ER - TY - JOUR AU - Devlin, N. J. AU - Brooks, R. PY - 2017 DA - 2017// TI - EQ-5D and the EuroQol group: past, present and future JO - Appl Health Econ Health Policy VL - 15 UR - https://doi.org/10.1007/s40258-017-0310-5 DO - 10.1007/s40258-017-0310-5 ID - Devlin2017 ER - TY - JOUR AU - Chen, H. AU - Blanc, P. D. AU - Chawla, A. AU - Hayden, M. AU - Bleecker, E. R. AU - Lee, J. H. PY - 2006 DA - 2006// TI - Assessing Productivity Impairment in Patients with Severe or Difficult-to-Treat Asthma: Validation of the Work Productivity Activity Impairment - Asthma Questionnaire JO - Journal of Allergy and Clinical Immunology VL - 117 UR - https://doi.org/10.1016/j.jaci.2005.12.721 DO - 10.1016/j.jaci.2005.12.721 ID - Chen2006 ER - TY - JOUR AU - Reilly, M. AU - Mitchell, I. AU - Gooch, K. AU - Vo, P. AU - Virabhak, S. AU - Lorimer, M. AU - Ruff, M. AU - Seidenberg, J. AU - Khong, H. PY - 2012 DA - 2012// TI - PRM29 Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI: CHRI) in Germany and Canada JO - Value in Health VL - 15 UR - https://doi.org/10.1016/j.jval.2012.08.280 DO - 10.1016/j.jval.2012.08.280 ID - Reilly2012 ER - TY - JOUR AU - Ramsey, B. W. AU - Davies, J. AU - McElvaney, N. G. AU - Tullis, E. AU - Bell, S. C. AU - Dřevínek, P. PY - 2011 DA - 2011// TI - A CFTR potentiator in patients with cystic fibrosis and the G551D mutation JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1105185 DO - 10.1056/NEJMoa1105185 ID - Ramsey2011 ER - TY - JOUR AU - Davies, J. C. AU - Wainwright, C. E. AU - Canny, G. J. AU - Chilvers, M. A. AU - Howenstine, M. S. AU - Munck, A. PY - 2013 DA - 2013// TI - Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation JO - Am J Respir Crit Care Med VL - 187 UR - https://doi.org/10.1164/rccm.201301-0153OC DO - 10.1164/rccm.201301-0153OC ID - Davies2013 ER - TY - JOUR AU - McKone, E. F. AU - Borowitz, D. AU - Dřevínek, P. AU - Griese, M. AU - Konstan, M. W. AU - Wainwright, C. PY - 2014 DA - 2014// TI - Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST) JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70218-8 DO - 10.1016/S2213-2600(14)70218-8 ID - McKone2014 ER - TY - JOUR AU - Quittner, A. AU - Suthoff, E. AU - Rendas-Baum, R. AU - Bayliss, M. S. AU - Sermet-Gaudelus, I. AU - Castiglione, B. PY - 2015 DA - 2015// TI - Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial JO - Health Qual Life Outcomes VL - 13 UR - https://doi.org/10.1186/s12955-015-0293-6 DO - 10.1186/s12955-015-0293-6 ID - Quittner2015 ER - TY - JOUR AU - Rowe, S. M. AU - Heltshe, S. L. AU - Gonska, T. AU - Donaldson, S. H. AU - Borowitz, D. AU - Gelfond, D. PY - 2014 DA - 2014// TI - Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis JO - Am J Respir Crit Care Med VL - 190 UR - https://doi.org/10.1164/rccm.201404-0703OC DO - 10.1164/rccm.201404-0703OC ID - Rowe2014 ER - TY - JOUR AU - Nolan, C. M. AU - Longworth, L. AU - Lord, J. AU - Canavan, J. L. AU - Jones, S. E. AU - Kon, S. S. PY - 2016 DA - 2016// TI - The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference JO - Thorax VL - 71 UR - https://doi.org/10.1136/thoraxjnl-2015-207782 DO - 10.1136/thoraxjnl-2015-207782 ID - Nolan2016 ER - TY - JOUR AU - Quittner, A. l. e. x. a. n. d. r. a. L. AU - Goldbeck, L. u. t. z. AU - Abbott, J. a. n. i. c. e. AU - Duff, A. l. i. s. t. a. i. r. AU - Lambrecht, P. a. t. r. i. c. k. AU - Solé, A. m. p. a. r. o. AU - Tibosch, M. a. r. i. j. k. e. M. AU - Bergsten Brucefors, A. g. n. e. t. a. AU - Yüksel, H. a. s. a. n. AU - Catastini, P. a. o. l. a. AU - Blackwell, L. a. u. r. a. AU - Barker, D. a. v. e. PY - 2014 DA - 2014// TI - Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries JO - Thorax VL - 69 UR - https://doi.org/10.1136/thoraxjnl-2014-205983 DO - 10.1136/thoraxjnl-2014-205983 ID - Quittner2014 ER - TY - JOUR AU - Quittner, A. l. e. x. a. n. d. r. a. L. AU - Abbott, J. a. n. i. c. e. AU - Georgiopoulos, A. n. n. a. M. AU - Goldbeck, L. u. t. z. AU - Smith, B. e. t. h. AU - Hempstead, S. a. r. a. h. E. AU - Marshall, B. r. u. c. e. AU - Sabadosa, K. a. t. h. r. y. n. A. AU - Elborn, S. t. u. a. r. t. PY - 2015 DA - 2015// TI - International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety JO - Thorax VL - 71 UR - https://doi.org/10.1136/thoraxjnl-2015-207488 DO - 10.1136/thoraxjnl-2015-207488 ID - Quittner2015 ER - TY - JOUR AU - Lechtzin, N. AU - Allgood, S. AU - Hong, G. AU - Riekert, K. AU - Haythornthwaite, J. A. AU - Mogayzel, P. PY - 2016 DA - 2016// TI - The association between pain and clinical outcomes in adolescents with cystic fibrosis JO - J Pain Symptom Manag VL - 52 UR - https://doi.org/10.1016/j.jpainsymman.2016.03.023 DO - 10.1016/j.jpainsymman.2016.03.023 ID - Lechtzin2016 ER - TY - JOUR AU - Hayes, M. AU - Yaster, M. AU - Haythornthwaite, J. A. AU - Riekert, K. A. AU - Nelson McMillan, K. AU - White, E. PY - 2011 DA - 2011// TI - Pain is a common problem affecting clinical outcomes in adults with cystic fibrosis JO - Chest VL - 140 UR - https://doi.org/10.1378/chest.11-0132 DO - 10.1378/chest.11-0132 ID - Hayes2011 ER - TY - JOUR AU - Quittner, A. l. e. x. a. n. d. r. a. L. AU - Modi, A. v. a. n. i. C. AU - Wainwright, C. l. a. i. r. e. AU - Otto, K. e. l. l. y. AU - Kirihara, J. e. a. n. AU - Montgomery, A. B. r. u. c. e. PY - 2009 DA - 2009// TI - Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection JO - Chest VL - 135 UR - https://doi.org/10.1378/chest.08-1190 DO - 10.1378/chest.08-1190 ID - Quittner2009 ER - TY - JOUR AU - Comer, D. M. AU - Ennis, M. AU - McDowell, C. AU - Beattie, D. AU - Rendall, J. AU - Hall, V. PY - 2009 DA - 2009// TI - Clinical phenotype of cystic fibrosis patients with the G551D mutation JO - QJM VL - 102 UR - https://doi.org/10.1093/qjmed/hcp120 DO - 10.1093/qjmed/hcp120 ID - Comer2009 ER - TY - JOUR AU - Dupuis, A. AU - Keenan, K. AU - Ooi, C. Y. AU - Dorfman, R. AU - Sontag, M. K. AU - Naehrlich, L. PY - 2016 DA - 2016// TI - Prevalence of meconium ileus marks the severity of mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene JO - Genet Med VL - 18 UR - https://doi.org/10.1038/gim.2015.79 DO - 10.1038/gim.2015.79 ID - Dupuis2016 ER - TY - JOUR AU - Hamosh, A. AU - King, T. M. AU - Rosenstein, B. J. AU - Corey, M. AU - Levison, H. AU - Durie, P. PY - 1992 DA - 1992// TI - Cystic fibrosis patients bearing both the common missense mutation Gly >Asp at codon 551 and the ∆F508 mutation are clinically indistinguishable from ∆F508 homozygotes, except for decreased risk of meconium ileus JO - Am J Hum Genet VL - 51 ID - Hamosh1992 ER - TY - JOUR AU - McKone, E. F. AU - Emerson, S. S. AU - Edwards, K. L. AU - Aitken, M. L. PY - 2003 DA - 2003// TI - Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study JO - Lancet VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)13368-5 DO - 10.1016/S0140-6736(03)13368-5 ID - McKone2003 ER - TY - JOUR AU - Sawicki, G. S. AU - McKone, E. F. AU - Millar, S. J. AU - Pasta, D. J. AU - Konstan, M. W. AU - Lubarsky, B. PY - 2017 DA - 2017// TI - Patients with cystic fibrosis and a G551D or homozygous F508del mutation: similar lung function decline JO - Am J Respir Crit Care Med VL - 195 UR - https://doi.org/10.1164/rccm.201608-1678LE DO - 10.1164/rccm.201608-1678LE ID - Sawicki2017 ER - TY - JOUR AU - McCormick, J. AU - Mehta, G. AU - Olesen, H. V. AU - Viviani, L. AU - Macek, M. AU - Mehta, A. PY - 2010 DA - 2010// TI - Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)62161-9 DO - 10.1016/S0140-6736(09)62161-9 ID - McCormick2010 ER -